Breast cancer
Also known as: Breast carcinoma, Mammary carcinoma, Malignant neoplasm of the breast
Breast cancer comprises malignant neoplasms of mammary tissue, necessitating rigorous histopathology, staging, and biomarker-directed oncological management. While surgical intervention, radiotherapy, and systemic therapies constitute the standard of care, Chinese medicine may be considered for adjunctive symptom management. Current clinical evidence remains equivocal: a small sham-controlled trial involving post-chemotherapy patients observed improvements in sleep parameters, although the primary difference in insomnia scores did not attain clinical significance [4]. A comprehensive review supports cautious integrative care but emphasizes variable evidence levels and significant potential for herb–drug interactions [1]. Bibliometric research has not established clinical efficacy [3], and in vitro findings regarding breast cancer cell lines do not translate to demonstrated patient benefit [2]. The TCM patterns described herein serve as traditional frameworks for symptomatic management and do not address tumour biology; the specified acupuncture point combinations and herbal formulas are not validated treatments for breast cancer.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Prioritise all oncology appointments and adherence to prescribed pharmacological regimens; provide the clinical team with a comprehensive list of all botanical or nutritional supplements.
- •Select tolerable meals and fluids and seek dietitian review for poor oral intake; avoid restrictive 'anticancer' diets.
- •Undertake comfortable, graded physical activity agreed upon with the treating team, with modifications for fatigue, bone disease, and lymphoedema.
- •Adhere to a consistent circadian sleep–wake cycle and utilise professional psychological or peer support services for the management of emotional distress.
Cautions & Contraindications
- •Do not use acupuncture or herbs to delay biopsy, surgery, radiotherapy or systemic treatment. The supplied review identifies non-adherence and herb–drug interactions as important safety concerns.[]
- •Defer elective needling with fever, suspected infection, clinically significant neutropenia, thrombocytopenia or uncontrolled bleeding until oncology clearance. Use current blood results and local oncology thresholds; these operational precautions are not tested by the supplied abstracts.[]
- •Avoid needling into tumours, surgical wounds, irradiated or infected skin, ports and lymphoedematous areas. For an arm at risk after axillary treatment, favour alternative sites and obtain team guidance. These are general site precautions, not conclusions from the supplied trial.[]
- •No listed herbal formula has demonstrated breast cancer treatment benefit or compatibility with modern oncology regimens in the supplied evidence. Obtain oncology-pharmacist review before considering any formula, particularly with anticoagulants, endocrine therapy or impaired organ function.[]
- •The absence of severe adverse events in a small post-chemotherapy insomnia trial does not establish safety during active chemotherapy, pregnancy or significant immunosuppression; assess these populations separately.[]
When to reassess or seek care again
Record baseline sleep diary and Insomnia Severity Index when relevant, plus 0–10 fatigue, nausea and pain scores, appetite and functional goals. Review after 2 weeks for tolerability and at 4–5 weeks for meaningful symptom and function change. Stop or modify adjunctive care if benefit is absent, burden is excessive or adverse effects occur. Refer sooner for worsening pain, weight loss, persistent insomnia, deteriorating function or suspected treatment toxicity; red flags require immediate escalation.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Journal of multidisciplinary healthcare · 2026
- Fitoterapia · 2026
- Journal of visualized experiments : JoVE · 2026
- Nature and science of sleep · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
